News
3d
News-Medical.Net on MSNGLP-1 agonists may reshape the gut microbiomeResearch reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...
People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.
In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...
As a large proportion of people taking medications like Mounjaro, Ozempic and Wegovy for weight loss report consuming less ...
PharmaZee’s weight loss program has gained significant attention for its use of GLP-1 agonists, such as Semaglutide and Tirzepatide, which have been scientifically proven to aid in weight loss ...
The rising use of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss is changing how Americans eat, with implications already visible in the food and beverage industry. A new study from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results